HealthMore in Health→
FDA clears first approved treatment for chronic hepatitis D
Key Takeaways
- Hepcludex is the first FDA-approved therapy for chronic HDV.
- The drug was approved under the Accelerated Approval pathway.
- A boxed warning notes risk of severe flare-ups after discontinuation.
DE
DT Editorial Team··via medicalxpress.com